Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation
Ginkgo Bioworks (NYSE: DNA) has scheduled its third quarter 2024 business performance presentation and Q&A session for Tuesday, November 12, 2024, at 5:30 p.m. ET, after market close. The presentation will cover results for the quarter ended September 30, 2024. Investors can access the webcast through Ginkgo's investor relations website, where a replay will also be available. Questions can be submitted beforehand via X (using #GinkgoResults) or email.
Ginkgo Bioworks (NYSE: DNA) ha programmato la sua presentazione sulle performance aziendali del terzo trimestre 2024 e la sessione di domande e risposte per martedì 12 novembre 2024, alle 17:30 ET, dopo la chiusura del mercato. La presentazione coprirà i risultati del trimestre chiuso il 30 settembre 2024. Gli investitori possono accedere alla diretta web tramite il sito di relazioni con gli investitori di Ginkgo, dove sarà disponibile anche una registrazione. Le domande possono essere inviate in anticipo tramite X (utilizzando #GinkgoResults) o email.
Ginkgo Bioworks (NYSE: DNA) ha programado su presentación sobre el rendimiento empresarial del tercer trimestre de 2024 y la sesión de preguntas y respuestas para el martes 12 de noviembre de 2024, a las 5:30 p.m. ET, después del cierre del mercado. La presentación cubrirá los resultados del trimestre que terminó el 30 de septiembre de 2024. Los inversores pueden acceder al webcast a través del sitio web de relaciones con inversores de Ginkgo, donde también estará disponible una repetición. Las preguntas pueden ser enviadas de antemano a través de X (usando #GinkgoResults) o por correo electrónico.
징코 바이오웍스(Ginkgo Bioworks) (NYSE: DNA)는 2024년 3분기 비즈니스 성과 발표 및 Q&A 세션을 2024년 11월 12일 화요일 오후 5시 30분 ET에 시장 마감 후 개최할 예정입니다. 이 발표에서는 2024년 9월 30일로 종료된 분기의 결과에 대해 다룰 것입니다. 투자자는 징코의 투자자 관계 웹사이트를 통해 웹캐스트에 접근할 수 있으며, 재방송도 제공될 것입니다. 질문은 미리 X를 통해 (#GinkgoResults 사용) 또는 이메일로 제출할 수 있습니다.
Ginkgo Bioworks (NYSE: DNA) a prévu sa présentation de la performance commerciale du troisième trimestre 2024 et une session de questions-réponses pour le mardi 12 novembre 2024 à 17h30 ET, après la fermeture du marché. La présentation couvrira les résultats du trimestre clos le 30 septembre 2024. Les investisseurs peuvent accéder au webcast via le site de relations avec les investisseurs de Ginkgo, où un replay sera également disponible. Les questions peuvent être soumises à l'avance via X (en utilisant #GinkgoResults) ou par email.
Ginkgo Bioworks (NYSE: DNA) hat seine Präsentation zur Unternehmensleistung für das 3. Quartal 2024 sowie die Q&A-Session auf Dienstag, den 12. November 2024, um 17:30 Uhr ET nach Börsenschluss angesetzt. Die Präsentation wird die Ergebnisse des zum 30. September 2024 abgeschlossenen Quartals behandeln. Investoren können auf den Webcast über die Investor-Relations-Website von Ginkgo zugreifen, wo ebenfalls eine Wiederholung verfügbar sein wird. Fragen können im Voraus über X (unter Verwendung von #GinkgoResults) oder per E-Mail eingereicht werden.
- None.
- None.
Presentation and Q&A session scheduled for post-market on Tuesday, November 12, 2024
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2024-results-presentation-302295611.html
SOURCE Ginkgo Bioworks
FAQ
When will Ginkgo Bioworks (DNA) release Q3 2024 earnings?
How can I access Ginkgo Bioworks (DNA) Q3 2024 earnings call?
How can investors submit questions for Ginkgo Bioworks (DNA) Q3 2024 earnings call?
